Keppra

Keppra treats partial-onset seizures in patients who are at least sixteen years old and have newly-diagnosed epilepsy. Keppra is an adjunctive therapy for 1.) Partial-onset seizures in adults and children older than 4 years old; 2.) – Myoclonic seizures in adults and adolescents older than 12 years old with Juvenile Myoclonic Epilepsy; and 3.) – Primary generalized tonic-clonic seizures in adults and adolescents older than 12 years of age with Idiopathic Generalised Epilepsy.